Last reviewed · How we verify
Additional ocular hypotensive medication
At a glance
| Generic name | Additional ocular hypotensive medication |
|---|---|
| Sponsor | Robin, Alan L., M.D. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Lens Extraction in Patients With Pseudoexfoliation Glaucoma (NA)
- An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: